Nicht aus der Schweiz? Besuchen Sie lehmanns.de
Quality Control in the age of Risk Management, An Issue of Clinics in Laboratory Medicine -

Quality Control in the age of Risk Management, An Issue of Clinics in Laboratory Medicine

Buch | Hardcover
217 Seiten
2013
Elsevier - Health Sciences Division (Verlag)
978-1-4557-7110-3 (ISBN)
CHF 109,95 inkl. MwSt
  • Versand in 15-20 Tagen
  • Versandkostenfrei
  • Auch auf Rechnung
  • Artikel merken
In October of 2011, CLSI published a new guideline EP23A on "Laboratory Quality Control Based on Risk Management.” In March, 2012, CMS announced its intention to incorporate key concepts from EP23A into its Interpretative Guidelines and QC policy for "Individualized Quality Control Plans.” Thus begins a new era of Quality Control in the Age of Risk Management. This issue is intended to help laboratories with the transition between traditional QC practices and the new risk management approach. Laboratories face a steep learning curve to apply risk analysis for identifying and prioritizing failure-modes, developing and implementing control mechanisms to detect those failure-modes, and assessing the acceptability of the residual risks that exist after implementation of a QC Plan. One of the main benefits of the new risk analysis based QC Plans should be an integration of all the control mechanisms that are needed to monitor the total testing process, including pre-analytic, analytic, and post-analytic controls. One of the main risks of the new approach is an expectation that Statistical QC is no longer important, even though SQC still remains the most useful and flexible approach for monitoring the quality of the analytic process. The key to the future is the successful integration of all these control mechanisms to provide a cost-effective quality system that monitors all phases of the total testing process. This issue should help laboratories understand the evolution of QC practices to include risk management, but also to recognize the need to maintain traditional techniques such as Statistical QC, especially during the transition to well-designed and carefully-validated QC Plans. Risk analysis may be risky business unless laboratories proceed carefully and cautiously.
Erscheint lt. Verlag 28.3.2013
Reihe/Serie The Clinics: Internal Medicine
Zusatzinfo Illustrations
Verlagsort Philadelphia
Sprache englisch
Maße 152 x 229 mm
Gewicht 460 g
Themenwelt Medizinische Fachgebiete Innere Medizin Hämatologie
Studium 2. Studienabschnitt (Klinik) Pathologie
ISBN-10 1-4557-7110-4 / 1455771104
ISBN-13 978-1-4557-7110-3 / 9781455771103
Zustand Neuware
Haben Sie eine Frage zum Produkt?
Mehr entdecken
aus dem Bereich
Hämatologie und Internistische Onkologie

von Dietmar P. Berger; Monika Engelhardt; Justus Duyster

Buch | Softcover (2023)
ecomed-Storck GmbH (Verlag)
CHF 179,95